Skip to content
Search

Latest Stories

UK doctor couple seek judicial review over 'risky' PPE guidance

A BRITISH-INDIAN doctor couple are seeking judicial review proceedings against the UK government over “risky” guidance issued on the use of personal protective equipment (PPE) across the NHS.

Dr Nishant Joshi and his pregnant wife, Dr Meenal Viz, had launched legal action last month, after writing for explanations from the Department of Health and Social Care, and Public Health England.


They decided to push ahead with the case in the London High Court after receiving “unconvincing” responses from the government.

"We asked simple questions one month ago, hoping for open dialogue and swift resolution with (Health Secretary) Matt Hancock. In that time, over 100 more healthcare and social workers have died,” the couple said.

“There is a human cost to this suffering – we have fielded many calls from bereaved families, many of whom have questions about Personal Protective Equipments and systemic failings. They are going through the worst grief and trauma of their lives, and they deserve answers,” they said.

The legal challenge against the guidance, which applies to healthcare and social care workers, claims that it reduces the requirement to wear Personal Protective Equipments (PPE) and allows for re-use of some PPE.

It is argued that this goes against World Health Organisation (WHO) guidance and puts healthcare workers at risk, breaching their legal protections at work and their human rights.

The couple’s legal team said the government not only took over two weeks to respond to the initial legal letter but also did not answer all the concerns.

They also claim that the government has refused to allow the publication of the initial response.

Jamie Potter, partner at Bindmans LLP and solicitor for the doctors, said: "The government continues to seek to avoid transparency as to the risks such workers are facing with different levels of PPE and confirmation they are entitled to refuse to work where they consider the risks too great.

“They should be entitled to compliance with WHO guidelines for all of their work. The government may be facing operational pressures, but it is nothing compared to the pressures and risks faced by frontline health care workers with inadequate PPE."

Estelle Dehon, from Cornerstone Barristers, representing the couple in court, added: “The WHO guidelines are designed to maintain those protections despite acute shortages of PPE and the government has not explained why it has taken a different approach that causes greater risk for frontline staff."

Joshi and Viz have also launched a crowdfunding campaign for the legal challenge, which has already attracted over £35,000 in pledges on the crowdjustice.com forum.

Joshi, a general practitioner (GP) trainee, has been leading a social media campaign for weeks over the safety guidance and supply of PPE for medical staff.

Viz, a clinical fellow in medicine, was pictured last month outside Downing Street dressed in full medical scrubs and a surgical mask holding a placard reading: “Protect Healthcare Workers”.

"My wife Meenal and I are both doctors. Like so many NHS workers we are deeply concerned about the lack of proper personal protective equipment (PPE) when we are working to help patients," wrote Joshi on crowdjustice.com.

"So far, over a hundred health care workers have died from coronavirus and many more have caught the disease. We're launching a legal challenge over government guidance on PPE which we believe exposes us to coronavirus."

The couple said it was "wonderful" that the country came together to clap and cheer frontline workers on on Thursday evenings. But, they added, it was also "critical that frontline NHS staff have the proper masks, visors, gowns, gloves, etc. so we can get on and help patients without fear of catching the virus ourselves and spreading it further".

The Department of Health did not comment on the legal challenge directly, but had previously stressed that measures are in place to minimise risk.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less